Reflexionmedical
Hayward, US · 6 known investors
RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease. The technology is used by cancer treatment centers, including freestanding cancer centers and hospital outpatient departments, to treat solid tumors at any stage.
BiotechHealthtechMedical Devices
Investors · 6
Founder mafia
2 people who came through Reflexionmedical went on to found or lead other companies.
Frequently asked questions
- What does Reflexionmedical do?
- RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease. The technology is used by cancer treatment centers, including freestanding cancer centers and hospital outpatient departments, to treat solid tumors at any stage.
- Who are Reflexionmedical's investors?
- Reflexionmedical's investors include Ascension Ventures, Catalio Capital Management, LP, Pfizer Venture Investments, Sofinnova Partners, Sonder Capital, Sonder Futures.
- Where is Reflexionmedical headquartered?
- Reflexionmedical is headquartered in Hayward, US.